← All indications
Uterine Hemorrhage
Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.
Subtype terms (3)
More specific conditions that are subtypes of Uterine Hemorrhage in the MeSH hierarchy.
- Menorrhagia
36 drugs (23 approved, 13 experimental)
- Metrorrhagia
20 drugs (15 approved, 5 experimental)
- Postpartum Hemorrhage
55 drugs (39 approved, 16 experimental)
Drugs by status
Approved for this indication (5)
Phase 4 trials (6)
Phase 3 trials (7)
Phase 2 trials (2)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (13)
- Merck
- Bayer
- Cairo University
- Kaiser Permanente
- Thomas Jefferson University
- University of Milan
- University of California, Davis
- University of California, Los Angeles
- Vanderbilt University
- Women's Health Care Clinic, Torrance, California
- University of Sao Paulo
- AMAG Pharmaceuticals, Inc.
- Washington University in St. Louis
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (8)